Sedative effect of Clozapine is a function of 5-HT2A and environmental novelty.
Title | Sedative effect of Clozapine is a function of 5-HT2A and environmental novelty. |
Publication Type | Journal Article |
Year of Publication | 2017 |
Authors | Joshi RS, Quadros R, Drumm M, Ain R, Panicker MM |
Journal | Eur Neuropsychopharmacol |
Volume | 27 |
Issue | 1 |
Pagination | 70-81 |
Date Published | 12/2016 |
ISSN | 1873-7862 |
Abstract | Antipsychotic drugs are the mainstay in the treatment of schizophrenia and bipolar disorder. However, antipsychotics often exhibit sedation or activity suppression among many other side effects, and the factors that influence them remain poorly understood. We now show, using a 5-HT2A knockout (Htr2a(-/-)) mouse, that environmental circumstances can affect suppression of activity induced by the atypical antipsychotic- Clozapine. We observed that Htr2a(-/-) mice were more resistant to Clozapine-induced suppression of activity (CISA) and this behaviour was dependent on the environment being 'novel'. In their 'home' environment, at identical doses the mice exhibited CISA. Interestingly, the effect of genotype and environmental novelty on CISA could not be extended to the other antipsychotics that were tested, i.e. Haloperidol and Risperidone. Haloperidol-induced activity suppression was independent of context and genotype. Whereas context affected Risperidone-induced activity suppression only in the Htr2a(+/+) mice. Furthermore, we observed that caffeine, a stimulant, elicited resistance to CISA similar to that seen in the 'novel' context. Our study establishes a previously unknown interaction between the environmental context, 5-HT2A and CISA and emphasises the role of non-pharmacological factors such as environment on the effects of the drug, which seem antipsychotic-specific. Our findings should advance the understanding of the side effects of individual antipsychotics and the role of environment to overcome side effects such as sedation. |
DOI | 10.1016/j.euroneuro.2016.10.007 |
Alternate Journal | Eur Neuropsychopharmacol |
PubMed ID | 27955831 |